Clinical Trial Update: Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup [Phase 3]

View source ↗

Summary

Phase 3 update reporting completion of a second extension study evaluating safety, tolerability, immunogenicity, and co-administration of influenza vaccines wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Novartis | Conditions: Influenza | Phase 3 | Status: COMPLETED | Results posted: 2011-10-10